Xencor, Inc.
NASDAQ:XNCRBiotechnology
-$0.13 today
- Market cap
- $2.58B
- Beta
- 0.93
- P/E (TTM)
- -5.5
- EPS (TTM)
- -$2.29
Volume 0.87M
Average 0.80M
XNCR EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Xencor, Inc.NASDAQ: XNCR
EBITDA · Q2 FY2026 · quarter ended Jun 2026
EBITDA remains negative
Q2 FY2026 EBITDA was -$12.13M, compared with -$20.18M a year earlier. Trailing-twelve-month EBITDA was -$123.6M.
Context
- EBITDA amounted to 37.4% of revenue in FY2025, down 131.1 pp from a year earlier.
- EBITDA grew in size in 2 of the last 3 fiscal years.
What to watch
Whether EBITDA reaches the consensus estimate from 8 analysts of -$136.19M (-189.9%) for the fiscal year ending Dec 2026, a slowdown from the +74.8% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- -$12.13M+90.0% QoQ
- Last fiscal yearDec 2025
- -$46.98M+74.8% YoY
- LTMJun 2026
- -$123.6M-14.3% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +39.9% | -569.1% | -609.0 pp |
| 1 year | +74.8% | -189.9% | -264.6 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- (46.98M) USD
- Year-over-year change
- +74.8%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (46.98M) | +74.8% |
| FY2024 | 2024-12-31 | (186.17M) | -82.6% |
| FY2023 | 2023-12-31 | (101.96M) | -123.1% |
| FY2022 | 2022-12-31 | (45.7M) | -150.7% |
| FY2021 | 2021-12-31 | 90.14M | — |
EBITDA vs competitors
How XNCR compares with its peers on the latest reported figures
- Peers report in different currencies, so EBITDA is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -14.3% is the 6th highest of 9, against a peer median of -0.0%.
- EBITDA amounts to 117.7% of revenue for XNCR, versus a peer median of 147.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.22B USD | — | -43.3% | 29.5% | |
| LTM Aug 2026 | $322.61M USD | +243.1% | — | 46.0% | |
| LTM Mar 2026 | $34.88M USD | +463.6% | — | 48.0% | |
| LTM Mar 2026 | $6.24M USD | +2711.1% | — | 1.6% | |
| LTM Jun 2024 | -$36.06M USD | — | — | 4420.7% | |
| FY2025 | -€43.65M EUR | +7.0% | — | 1566.1% | |
| LTM Mar 2026 | -$50.64M USD | -7.0% | — | 32.2% | |
| FY2025 | -A$62.88M AUD | -41.2% | — | 1246.6% | |
| LTM Jun 2026 | -$123.6M USD | -14.3% | — | 117.7% | |
| LTM Jun 2026 | -$134.39M USD | -53.9% | — | 246.2% | |
| LTM Sep 2026 | -$305.37M USD | -38.1% | — | 272652.7% | |
| Peer median (excluding XNCR) | — | -0.0% | -43.3% | 147.1% | |
Competitors are the stored peer set for XNCR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 275.11M | 164.58M | 174.62M | 110.49M | 125.58M |
| Cost of Revenue | 192.51M | 199.56M | 0 | 227.69M | 10.51M |
| Gross Profit | 82.6M | (34.98M) | 174.62M | (117.19M) | 115.06M |
| Gross Margin | 30.0% | -21.3% | 100.0% | -106.1% | 91.6% |
| Research & Development | 192.51M | 199.56M | 253.6M | 227.69M | 239.43M |
| Selling, General & Admin | 38.84M | 47.49M | 53.38M | 58.89M | 63.64M |
| Operating Expenses | 38.84M | 47.49M | 306.98M | 61.22M | 292.57M |
| Depreciation & Amortization | 7.49M | 8.8M | 11.5M | 12.11M | 10.51M |
| EBITDA | 90.14M | (45.7M) | (101.96M) | (186.17M) | (46.98M) |
| EBITDA Margin | 32.8% | -27.8% | -58.4% | -168.5% | -37.4% |
| Operating Income | 43.77M | (82.47M) | (132.36M) | (178.41M) | (177.5M) |
| Operating Margin | 15.9% | -50.1% | -75.8% | -161.5% | -141.4% |
| Interest Income | 862K | 4.82M | 18.63M | 31.93M | 27.52M |
| Interest Expense | 13K | 0 | 0 | 36.64M | 31.93M |
| Other Income / Expenses | 38.86M | 27.97M | 12.73M | (56.52M) | 87.87M |
| Income Before Tax | 82.63M | (54.51M) | (119.63M) | (234.92M) | (89.42M) |
| Pre-Tax Margin | 30.0% | -33.1% | -68.5% | -212.6% | -71.2% |
| Income Tax Expense | 0 | 673K | 13.66M | 1.62M | 2.5M |
| Net Income | 82.63M | (55.18M) | (133.13M) | (232.62M) | (91.92M) |
| Net Margin | 30.0% | -33.5% | -76.2% | -210.5% | -73.2% |
| EPS (Basic) | 1.42 | (0.93) | (2.08) | (3.58) | (1.24) |
| EPS (Diluted) | 1.37 | (0.93) | (2.08) | (3.58) | (1.24) |
| Weighted Avg Shares | 58.38M | 59.65M | 60.5M | 65.04M | 74.24M |
| Weighted Avg Shares (Diluted) | 60.5M | 59.65M | 60.5M | 65.04M | 74.24M |
Xencor, Inc.
NASDAQ:XNCR
Intrinsic Alpha fair value
Locked
Current Price
$34.39
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.